RIVANTA
Live / Allowed — Notice of allowance issued (as of 21 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99036443
- Mark type
- Stylized text
- Filed
- 11 Feb 2025
- Published for opposition
- 26 Aug 2025
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders.
Owner
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
Prosecution history
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jul 2025 — ASSIGNED TO EXAMINER
- 11 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 11 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Feb 2025 — NEW APPLICATION ENTERED